tirzepatide and colonoscopy Week 40 on #tirzepatide #weightloss #colonoscopy Holding GLP-1 Prior to Colonoscopy:
Description
Here is the evidence-based monitoring schedule recommended for semaglutide therapy
Clinical trial data have not shown increased risk of these malignancies
In our experience, transitioning directly to subcutaneous semaglutide 1 mg once weekly from another GLP-1 receptor agonist can be associated with nausea or GI disturbance
Plan carefully
Proper toilet posture facilitates easier bowel movements
Almost always from one thing: not drinking enough
